PTC Therapeutics, Inc. (PTCT) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ptc Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.494 Ladies and gentlemen, thank you for standing by. 00:00:02.494 -- 00:00:08.222 Welcome to PTC Therapeutics first quarter 2025 earnings conference call. 00:00:08.222 -- 00:00:11.105 All participants are in the listen only mode. 00:00:11.105 -- 00:00:13.929 After the presentation, there will be a question and answer session. 00:00:13.929 -- 00:00:18.595 Today's conference is being recorded. I would now like to turn the conference over to 00:00:18.595 -- 00:00:22.140 Ellen Cavalieri, head of investor relations. 00:00:22.140 -- 00:00:24.601 Please go ahead. 00:00:32.026 -- 00:00:36.933 Good afternoon, and thank you for joining us to discuss PTC Therapeutics' first quarter 00:00:36.933 -- 00:00:40.618 2025 corporate update and financial results. 00:00:40.618 -- 00:00:43.241 I'm joined today by our Chief Executive Officer, Dr. 00:00:43.241 -- 00:00:48.148 Matthew Klein, our Chief Business Officer, Eric Powles, and our Chief Financial Officer, 00:00:48.148 -- 00:00:50.131 Pierre Gravier. 00:00:50.131 -- 00:00:54.757 Today's call will include forward-looking statements based on our current expectations. 00:00:54.757 -- 00:00:59.284 These statements are subject to certain risks and uncertainties, and actual results may 00:00:59.284 -- 00:01:04.466 differ materially. Please review the slide posted on our investor relations website 00:01:04.466 -- 00:01:09.611 in conjunction with the call, which contains information about our forward-looking statements 00:01:09.611 -- 00:01:15.316 and our most recent quarterly report on Form 10-Q and annual report on Form 10-K 00:01:15.316 -- 00:01:20.500 filed with the SEC, as well as our other SEC filings for a detailed description 00:01:20.500 -- 00:01:25.104 of applicable risks and uncertainties that could...